Cardiomyopathy, Premature Ventricular Contraction (PVC), Ventricular Arrhythmia, Ventricular Tachycardia
Conditions
Keywords
Arrhythmia, Cardiac Conduction System Disease, Sudden Cardiac Death, Implantable Cardiac Defibrillator (ICD)
Brief summary
This is a prospective multi-center international registry. The objective of this registry is to collect prospective data on patients undergoing catheter ablation for Ventricular Tachycardia (VT) and Premature Ventricular Contractions (PVC). The registry will be used for clinical monitoring, research, and quality improvement purposes.
Detailed description
Sudden cardiac death (SCD), predominantly due to ventricular tachyarrhythmias, is a leading cause of mortality in the United States and around the world. Catheter ablation of ventricular arrhythmias has proven efficacious in reducing the burden of arrhythmias and reducing implantable cardiac defibrillator (ICD) shocks. The aim of this study is to create a prospective international database registry that will allow for better assessment of the outcomes of catheter ablation of ventricular arrhythmias. The registry, with approximately 30 participating centers, will help to identify the overall success rates and associated benefits of the procedure and provide more comprehensive data on understudied populations and treatment.
Interventions
None listed
Sponsors
University of California, Los Angeles
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
\- All patients undergoing catheter ablation for ventricular tachycardia (VT) or premature ventricular contractions (PVCs).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Ventricular tachycardia (VT) recurrence | From date of procedure assessed by shock, Anti-Tachycardia Pacing, or repeat procedure, up to 10 years. | Freedom from ventricular tachycardia episodes requiring ICD Intervention (shock or Anti-Tachycardia Pacing) or repeat procedure. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Time to transplant or death | From date of procedure assessed by date of transplant and/or death, up to 10 years. | — |
| Rate of complications | From date of procedure assessed up to 12 months. | Cardiovascular-related and procedure-related major complications and/or adverse events. |
Countries
Canada, Israel, Japan, Netherlands, Spain, United Kingdom, United States
Outcome results
None listed